LONDON, UK / ACCESSWIRE / June 27, 2016 / ActiveWallSt.com announces the list of stocks for today’s research coverage. Pre-market the Active Wall St. team provides the latest corporate, market and technical events impacting selected stocks on the Drug Manufacturers – Other industry. Companies recently under review include Novo Nordisk, Biodel, DURECT, and Sucampo Pharma. See our complete report on Novo Nordisk at:

http://www.activewallst.com/registration-3/?symbol=NVO

Today, ActiveWallSt.com is promoting its equity research coverage. Get all of our research report free by signing up to http://www.activewallst.com/register/

Steady growth in expected for the Drug Manufacturers industry given its continuous efforts to address concerns in pricing and delivery. Let us see how this is affecting some of the big names in the industry. Register with us now for your free membership and more research reports at

http://www.activewallst.com/register/

ActiveWallSt.com takes a brief technical look at how each of the companies mentioned above have fared following last Friday’s close and over the last few trading sessions.

Novo Nordisk A/S (NYSE: NVO)

Bagsvaerd, Denmark headquartered Novo Nordisk A/S’s shares recorded a trading volume of 1.59 million shares, which was above their three months average volume of 1.31 million shares. The stock finished the trading session 4.38% lower at $51.06. The Company’s are trading below their 200-day moving averages by 5.64%. Furthermore, shares of Novo Nordisk, which engages in the discovery, development, manufacture, and marketing of pharmaceutical products globally, have a Relative Strength Index (RSI) of 34.75.

Biodel Inc. (NASDAQ: BIOD)

Last Friday, Danbury, Connecticut headquartered specialty biopharmaceutical Company, Biodel Inc.’s stock recorded a trading volume of 832,840 shares and ended the session at 16.81% lower at $0.26. The Company’s shares are trading 28.06% below their 200-day moving average. The stock has an RSI of 27.45. The complimentary report on BIOD can be downloaded at:

http://www.activewallst.com/registration-3/?symbol=BIOD

DURECT Corp. (NASDAQ: DRRX)

Cupertino, California DURECT Corp.’s shares ended the day 2.42% higher at $1.27. The stock recorded a trading volume of 1.71 million shares, which was above its three months average volume of 589,120 shares. The Company’s shares have gained 3.25% in the last month. The stock is trading 1.24% below its 50-day moving average. Additionally, shares of DURECT, which researches and develops therapies based on its epigenomic regulator program and proprietary drug delivery platforms, have an RSI of 48.57. Register for free and access the latest research report on DRRX at:

http://www.activewallst.com/registration-3/?symbol=DRDX

Sucampo Pharmaceuticals Inc. (NASDAQ: SCMP)

Shares in Rockville, Maryland headquartered Sucampo Pharmaceuticals Inc. recorded a trading volume of 651,344 shares, which was above their three months average volume of 546,870 shares. The stock ended Friday’s session 2.19% lower at $10.71. The Company’s shares have gained 6.67% over the previous three months. The stock is trading below its 50-day moving average by 4.72%. Furthermore, shares of Sucampo Pharmaceuticals, which focuses on the research and development of proprietary drugs for the treatment of gastrointestinal, ophthalmic, autoimmune, and oncology-based inflammatory disorders, have an RSI of 42.65. The complete research report on SCMP is available for free at:

http://www.activewallst.com/registration-3/?symbol=SCMP

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com
Phone number: 1-858-257-3144
Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 441660

LONDON, UK / ACCESSWIRE / June 27, 2016 / ActiveWallSt.com announces its coverage of market signals with highlight on these most active stocks from last Friday’s session: Microsoft Corp (NASDAQ: MSFT), AT&T, Inc. (NYSE: T), Cisco Systems, Inc. (NASDAQ: CSCO) and Oracle Corporation (NYSE: ORCL). Register with us now for your free membership and get more on our signal alerts at:

http://www.activewallst.com/register/

Stock Market Performance and Update

U.S. stock markets tumbled on Friday, June 24, 2016 after British public’s historic decision to leave the European Union set the global financial markets in turmoil. U.S. stocks gave up all their gains from earlier in the year.

The Dow Jones industrial average slumped 610.32 points, or 3.39%, to 17,400.75.

The NASDAQ composite posted its biggest loss since 2011, down 202.06 points, or 4.12% at 4,707.98.

The S&P 500 tumbled 75.91 points, or 3.59% closing at 2,037.41.

Today, ActiveWallSt.com is promoting its market signals coverage with emphasis on MSFT, T, CSCO, and ORCL. Get all of our reports for free by signing up to http://www.activewallst.com/register/.

Below we take a look at some of the most active share in the Technology Sector.

Most Active – Microsoft

Last Friday, shares in Microsoft Corp. recorded heavy trading volume of 133.21 million, higher than its three months average volume of 29.33 million shares. Microsoft’s stock ended the trading session at $49.83, down by 4.01%. The stock oscillated between an intraday range of $49.52 and $50.94. Microsoft’s shares traded at 38.42 times its trailing twelve month P/E ratio. On a yearly basis, the stock was up 12.19%. The company’s stock is trading 3.21% below its 50-day moving average and 2.53% below its 200-day moving average.

Most Active – AT&T

Shares of AT&T, Inc. finished last Friday’s trading session 0.86% lower at $41.52. A total of 57.12 million shares were traded, which was above its three months average volume of 20.70 million shares. The stock moved between $41.30 and $42.23 during the session. Over the last one month and the previous three months, AT&T’s shares have surged 7.51% and 7.59%, respectively. Since the beginning of 2016, the company’s stock has advanced 23.88%. The company’s shares are trading 5.83% above its 50-day average and 16.82% above its 200-day moving average. AT&T’s shares traded at 17.59 times its trailing twelve month P/E ratio.

Most Active – Cisco Systems

On Friday, June 24, 2016, shares in Cisco Systems, Inc. oscillated between $27.70 and $28.57 before ending the session 5.03% lower at $27.75. Cisco’s share reported a trading volume of 43.98 million shares, above its three months average volume of 22.51 million shares. Shares of the company traded at 13.74 times its trailing twelve month P/E ratio. Shares of Cisco have gained 3.91% on YTD. The stock is trading 1.29% below its 50-day moving average; while it is 3.73% above its 200-day moving averages.

Most Active – Oracle

Oracle Corporation’s stock declined 3.92%, closing the day at $39.23. The stock recorded a trading volume of 44.08 million shares, higher than its three months average volume of 12.79 million shares. Oracle’s stock vacillated between $39.02 and $39.89 during the session. Since the beginning of this year, Oracle’s shares have gained 8.24%. The stock is trading 1.50% below its 50-day moving average; while it is 3.09% above its 200-day moving averages. Further, shares of the company traded at 18.95 times its trailing twelve month P/E.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com
Phone number: 1-858-257-3144
Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 441663

LONDON, UK / ACCESSWIRE / June 27, 2016 / ActiveWallSt.com announces its upcoming earnings coverage as a number of major companies are set to announce their quarterly results throughout this week. Analysts’ consensus estimates and the trading history used below have been taken from Yahoo! Finance. Please note that the earnings and revenue estimates may change ahead of the formal announcement, while some companies might also alter their reporting dates. Register with us now for your free membership and see our complete earnings coverage on this equity at:

http://www.activewallst.com/register/

Today, ActiveWallSt.com is announcing its upcoming post-earnings coverage on Nike, Inc. (NYSE: NKE), Monsanto Co. (NYSE: MON), General Mills Inc. (NYSE: GIS) and Micron Technology, Inc. (NASDAQ: MU) Get all of our free coverage by signing up to http://www.activewallst.com/register/.

With the global markets still in turmoil after the shockwave results of the British Referendum which saw the U.K. leaving the European Union, ActiveWallSt.com looks at the companies below:

Earnings Preview – Nike, Inc.

Footwear Giant Nike, Inc. (NYSE: NKE) is scheduled to announce its Q4 Fiscal 2016 results on Tuesday, June 28, 2016 after the market close. Analysts’ consensus estimate for Q4 FY16 earnings is $0.47 per share on revenue of $8.27 billion. In its Q3 FY16 earnings announced on March 22, 2016, Nike topped earnings expectation; however the company disappointed investors with forecast well below estimates. The stock has a consensus analyst price target of $71.05 and is trading 24.35 times its trailing twelve month P/E ratio.

Since its previous earnings release, Nike’s stock is down 14.01%. For the year, the stock is up 1.01%.

Earnings Preview – Monsanto Co

Monsanto Co. (NYSE: MON) is expected to announce Q3 fiscal 2016 results on Wednesday, June 29, 2016. Analysts’ consensus estimate for Q3 FY16 earnings is $2.42 per share on revenue of $4.50 billion. For the seeds and agrochemicals company, this will be the first earnings results since it rejected the $62 billion acquisition offer from Bay AG in May 2016. Investors would be keen to know whether the deal can still go through. Monsanto has a consensus price target of $104.80 and is trading 33.01 times its trailing twelve month P/E ratio.

Since its previous earnings release on April 6, 2016, Monsanto’s stock has advanced 15.55%. Additionally, the stock is up 6.89% since the beginning of the year as compared to the S&P 500 which is down 0.32% during the same time frame.

Earnings Preview – General Mills Inc.

On Wednesday, Cheerios cereals and Yoplait maker General Mills Inc. (NYSE: GIS) is scheduled to report its Q4 fiscal 2016 earnings results premarket on Wednesday, June 29, 2016. Analysts’ consensus estimate for Q4 FY16 earnings is $0.60 per share on revenue of $3.86 billion. During the year ago period, the company had earnings of $0.75. General Mills is grappling with declining revenue as a result of a slowdown in cereal sales and strong U.S. dollar. General Mills has a consensus price target of $61.800 and is trading 27.03 times its trailing twelve month P/E ratio.

Since its previous earnings release on March 23, 2016, General Mills’ share price has gained 7.66%, while the stock is up 16.44% since the beginning of the year.

Earnings Preview – Micron Technology, Inc.

Chipmaker Micron Technology, Inc. (NASDAQ: MU) is set to report its Q3 fiscal 2016 earnings results on Thursday, June 30, 2016. Analysts’ consensus estimate for Q3 FY16 is net loss of $0.09 per share on revenue of $2.96 billion. Micron has been struggling with weak demand for its chips amid a slowdown in personal computer. Investors would look forward to company’s insights regarding chip demand and inventory for 2016. Micron has a consensus price target of $15.00 and is trading 13.70 times its trailing twelve month P/E ratio.

Since its previous earnings release on March 30, 2016, Micron Technology’s stock has gained 27.26.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com
Phone number: 1-858-257-3144
Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 441661

RADNOR, PA / ACCESSWIRE / June 27, 2016 / The law firm of Kessler Topaz Meltzer & Check, LLP announces that a shareholder class action lawsuit has been filed against CPI Card Group, Inc. (NASDAQ: PMTS) (“CPI Card” or the “Company”) on behalf of purchasers of the Company’s securities made pursuant or traceable to CPI Card’s initial public offering (“IPO”) on or around October 8, 2015.

CPI Card shareholders may, no later than August 15, 2016, petition the Court to be appointed as a lead plaintiff representative of the
class.

Shareholders who wish to discuss this action or request additional information about the lawsuit are encouraged to contact Kessler Topaz Meltzer & Check attorneys D. Seamus Kaskela or Adrienne O. Bell at (888) 299-7706 or online at: https://www.ktmc.com/new-cases/cpi-card-group-inc.

CPI Card is a “provider in payment card production and related services,” and offers among other products, “EMV cards” (also referred to as “chip cards”) that store data on integrated circuits rather than magnetic stripes. EMV chip cards help improve security against fraud as compared to magnetic stripe card transactions which rely on a cardholder’s signature and a visual inspection of the card. In recent years, credit and debit card issuers have substantially increased the level of EMV cards issued to account holders.

On October 8, 2015, CPI Card completed its IPO. The IPO was a financial success for the Company, certain of its senior executive officers and private investment funds, as they collectively sold 17.25 million shares of common stock to investors at $10.00 per share for gross proceeds of $172.5 million.

The complaint alleges that the Offering Materials issued in connection with the IPO were negligibly prepared, contained untrue statements of material facts, and omitted to state other necessary facts. Among other things, the complaint alleges that at the time of the Company’s IPO its largest EMV card customers were significantly over-inventoried with EMV cards, having increased purchases in the first half of 2015 far in excess of card issuance, resulting in a massive backlog of EMV card inventory for those customers. As a result, those large EMV card customers would significantly reduce their card purchases from CPI Card in the fiscal quarters following the IPO as they worked through their bloated card inventories.

On May 11, 2016, CPI Card reported disappointing first quarter 2016 financial and operational results and significantly reduced its fiscal 2016 financial outlook. As detailed in the earnings announcement, “The carryover into 2016 of unissued EMV card inventories at the large issuers and processors is much greater than anticipated, and accordingly, their EMV card purchases are being curtailed until inventories return to normal levels.” Following that earnings announcement the Company’s shares declined $3.65 per share, or over 47%, to close the following day at $4.01 per share. The closing price of CPI Card’s common stock on May 12, 2016 represented a decline of 60% from the price of the common stock sold to investors at the time of the IPO seven months prior.

CPI Card shareholders may,
no
later than August 15, 2016, petition the Court to be appointed as a lead plaintiff representative of the class through Kessler Topaz Meltzer & Check, or other counsel, or may choose to do nothing and remain an absent class member. A lead plaintiff is a representative party who acts on behalf of all class members in directing the litigation. In order to be appointed as a lead plaintiff, the Court must determine that the class member’s claim is typical of the claims of other class members, and that the class member will adequately represent the class in the action. Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff.

Kessler Topaz Meltzer & Check prosecutes class actions in state and federal courts throughout the country. Kessler Topaz Meltzer & Check is a driving force behind corporate governance reform, and has recovered billions of dollars on behalf of institutional and individual investors from the United States and around the world. The firm represents investors, consumers and whistleblowers (private citizens who report fraudulent practices against the government and share in the recovery of government dollars). The complaint in this action was not filed by Kessler Topaz Meltzer & Check. For more information about Kessler Topaz Meltzer & Check, or for additional information about participating in this action, please visit www.ktmc.com.

CONTACT:

Kessler Topaz Meltzer & Check, LLP
Darren J. Check, Esq.
D. Seamus Kaskela, Esq.
Adrienne O. Bell, Esq.
280 King of Prussia Road
Radnor, PA 19087
(888) 299-7706
(610) 667-7706

SOURCE: Kessler Topaz Meltzer & Check, LLP

ReleaseID: 441608

NEW YORK, NY / ACCESSWIRE / June 27, 2016 / SeeThruEquity, a leading independent equity research and corporate access firm focused on small-cap and micro-cap public companies, today announced it has issued an update on Progressive Care, Inc. (OTC: RXMD) with a price target of $0.10.

The report is available here: RXMD June 2016 Update. SeeThruEquity is an approved equity research contributor on Thomson First Call, Capital IQ, FactSet, and Zack’s. The report will be available on these platforms. The firm also contributes its estimates to Thomson Estimates, the leading estimates platform on Wall Street.

“We are maintaining our $0.10 price target for RXMD at this time. With strong recent results marked by positive Net Income and operating cash flow, RXMD represents an attractive growth story in the healthcare sector. It is also worth noting out that healthcare and related companies have some shielding against many of the factors recently affecting the broader equity markets – given the outsized role of regulation and healthcare-specific factors on the industry. We would think this would be true for RXMD as well – especially if it is able to continue to execute on its business objectives and show continued growth in revenues and cash flow leverage.,” stated Ajay Tandon, CEO of SeeThruEquity.

Additional highlights from the update are as follows:

Rising prescription demand drives record revenues in 1Q16

Progressive Care reported strong results in its first reporting quarter since we initiated coverage on the company in April. Results bolstered by strong demand for prescriptions, which grew by 30%+ to approximately 51,000 during the quarter. Progressive Care was able to grow revenue by 26.7% YoY, with the top line reaching $3.95mn – a record for the company – versus $3.12mn in 1Q15. The results position the company well to meet or exceed both our estimated revenues of $16.1mn and RXMD’s guidance of $16.0mn. Importantly, Progressive Care was able to achieve margin expansion as well, with gross margins improving by 280 basis points to 23.5% versus 20.7% in 1Q15. The company also generated GAAP Net Income and operating cash flow during the quarter.

Strong growth continues into 2Q16

Progressive Care’s strategy appears to be gaining traction in the market as the company has been successful in demonstrating strong growth over the last two years and continues to expand in 2016. After reporting strong April results in which prescriptions filled rose by 20% YoY to 16,500 and revenues came in at $1.4mn, the company reported nice sequential improvements in May, with $1.4mn in revenue and prescriptions filled rising to 17,500. This represented YoY growth of 22% and 28%, respectively.

Maintain price target of $0.10 for RXMD

We are maintaining our price target for RXMD at this time. We are impressed by 1Q16 results and see the company as on track to meet or exceed our estimates for the year. With strong recent results marked by positive net income and operating cash flow, RXMD represents an attractive growth story in the healthcare sector. It is also worth pointing out that healthcare and related companies have some shielding against the factors affecting the broader markets given the important role of regulation and industry-specific factors on the industry. We would think this would be true for RXMD as well, if it is able to continue to execute on its business objectives and show continued growth in revenues and cash flow. If achieved, the price target of $0.10 represents potential upside of 200% from the recent price of $0.04 and a potential Enterprise Value of $33.7mn, which we see as appropriate for a company growing at double-digit organic growth rates with $16mn in sales in FY16E and several potential additional catalysts ahead.

Please review important disclosures at www.seethruequity.com.

About Progressive Care, Inc.

Progressive Care, Inc. (OTC PINK: RXMD), through its subsidiary PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals specializing in health practice risk management, compounded medications, the sale of anti-retroviral medications and related medication therapy management, and the supply of prescription medications to long term care facilities.

For more information, please visit the company’s website at www.progressivecareus.com.

About SeeThruEquity

SeeThruEquity is an equity research and corporate access firm focused on companies with less than $1 billion in market capitalization. The research is not paid for and is unbiased. The company does not conduct any investment banking or commission based business. SeeThruEquity is approved to contribute its research to Thomson One Analytics (First Call), Capital IQ, FactSet, Zacks, and distribute its research to its database of opt-in investors. The company also contributes its estimates to Thomson Estimates, the leading estimates platform on Wall Street.

For more information visit www.seethruequity.com.

Contact:

Ajay Tandon
SeeThruEquity
info@seethruequity.com

SOURCE: SeeThruEquity

ReleaseID: 441650

TORONTO, ON / ACCESSWIRE / June 27, 2016 / Wi2Wi Corporation (Wi2Wi or the Company) (TSX-V: YTY), pleased to announce that Fundamental Research Corporation has initiated coverage on the Company and has issued an Initial Coverage research report dated June 24, 2016 entitled: “Wi2Wi Corporation: Positioning to Fully Capitalize on the Rapidly Growing IoT Market”. The research report can be obtained by contacting Siddharth Rajeev, B.Tech, MBA, CFA at:

Fundamental Research Corporation
Suite 308 – 1155 West Pender Street
Vancouver, BC V6E 2P4
Canada
Phone: 604-682-7050
Fax: 604-682-7001
Email: info@researchfrc.com

About Fundamental Research Corporation:

Founded in 2003, and based in Vancouver, British Columbia, Canada, Fundamental Research Corporation is an independent equity research firm, specializing in Small and Microcap public companies in following sectors; Technology, Energy, Mining, Exempt Markets, Biotech & Healthcare and Industrials. Since 2003, Fundamental Research Corp has provided the highest institutional quality equity research coverage on over 250 small and micro-cap public companies through their extensive distribution network. Since 2009, the company has also issued over 80 reports on exempt market securities. The company’s research is being used by some of the largest institutional investors in the world who access it through channels such as Reuters, Capital IQ, the Globe and Mail, and by subscription.

About IoT and M2M:

Essentially, IoT and M2M describe the network of physical objects or “things” embedded with electronics, software, sensors, and network connectivity, which enables these objects to collect and exchange data. Driven by several factors including the growth in the availability of Broadband Internet, which reduces the cost of connecting, and the related increase in Wi-Fi capabilities as well as sensors built into myriad technologies, this has been described as the “perfect storm” for the IoT. Almost any device with an on and off switch that can be connected to the Internet (and/or to each other) – anything from cell phones, coffee makers, washing machines, headphones, lamps, wearable devices, cars, as well as machine components in the engine of a jet airplane or the drill of an oil rig. According to analyst firm Gartner, by 2020 there will be over 26 billion connected devices. Others think this figure could be too conservative by a factor of four.

About Wi2Wi Corporation:

Wi2Wi is a vertically-integrated technology company which designs, manufactures and markets high performance, low power wireless connectivity solutions, global navigation satellite system (GNSS) modules, and frequency control devices. The Company’s products and services address numerous applications in the markets of Internet of Things (IoT), Machine to Machine (M2M), Avionics, Space, and Government Sponsored Projects. Wi2Wi’s products and value-added services provide highly integrated, rugged, robust, and reliable multiprotocol wireless actuators with embedded software, along with customized timing and frequency control devices for customers, worldwide. The Company was founded in 2005 and is strategically headquartered in San Jose, California with satellite offices in Middleton, Wisconsin and Hyderabad, India. Wi2Wi’s manufacturing operations, its laboratory for reliability and quality control, together with design and engineering for timing and frequency control devices are located in Middleton, WI. The branch office, located in Hyderabad, India, focuses on the development of wireless connectivity; both hardware and software. Wi2Wi’s strategic objective is to service the unique needs of each customer by providing end to end wireless integration solutions and highly customizable timing and frequency control devices. Wi2Wi distinguishes itself from commodity grade products, with best in the market performance, highly reliable, low power wireless connectivity products with integrated software that supports broader temperature ranges and a longer product life cycle. Furthermore, Wi2Wi’s end to end product solutions helps the customer substantially reduce their end product expense, certification cost, and overall R&D investment, in addition to substantially reducing the time to market. Wi2Wi has partnered with best in class global leaders in technology, manufacturing, and sales. The Company uses a wide network of manufacturer’s representatives, worldwide, to promote its products and services, and has partnered with world class distributors for the fulfillment of orders along with direct sales.

Forward-Looking Statements:

This news release contains certain forward-looking statements, including management’s assessment of future plans and operations, and the timing thereof, that involve substantial known and unknown risks and uncertainties, certain of which are beyond the Company’s control. Such risks and uncertainties include, without limitation, risks associated with the ability to access sufficient capital, the impact of general economic conditions in Canada, the United States and overseas, industry conditions, stock market volatility. The Company’s actual results, performance or achievements could differ materially from those expressed in, or implied by, these forward-looking statements and, accordingly, no assurances can be given that any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do so, what benefits, including the amount of proceeds, that the Company will derive there from. Readers are cautioned that the foregoing list of factors is not exhaustive. Additional information on these and other factors that could affect the Company’s operations and financial results are included in reports on file with Canadian securities regulatory authorities and may be accessed through the SEDAR website (www.sedar.com). Forward-looking statements are made based on management’s beliefs, estimates and opinions on the date the statements are made and the Company undertakes no obligation to update forward-looking statements and if these beliefs, estimates and opinions or other circumstances should change, except as required by applicable law. All subsequent forward-looking statements, whether written or oral, attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these cautionary statements. Furthermore, the forward-looking statements contained in this news release are made as at the date of this news release and the Company does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by applicable securities laws.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Wi2Wi Corporation

ReleaseID: 441647

 

• Brings 15+ Years of International Sales and Training Experience in the Fitness Industry
• Builds on Recently Expanding International Business That Already Comprises 40% of Company Sales

 

LAKE FOREST, CA / ACCESSWIRE / June 27, 2016 / XFit Brands, Inc. (OTCQB: XFTB), a global supplier of fitness and MMA equipment sold at retail and fitness outlets worldwide whose brands include Throwdown®, and Transformations™, today announced that Jeremy Strom, a senior fitness industry veteran with more than 15 years of international sales and programming experience has joined XFIT Brands as Vice-President of International Sales and Training.

XFit Brands has been growing compound annually in excess of 40% over the past three years, and is currently sold in 21 countries around the world. The recent expansion of the portfolio to a broader functional fitness line with kettle bells, dumbbells, barbells, and other functional fitness items coupled with the Company’s new international consolidated distribution partner EVB, has positioned the XFit Brands organization to further drive international growth.

Jeremy Strom has been a leader in the fitness and training industry for more than 15 years, and is joining XFit Brands at a key inflection point and acceleration moment in the Company’s history. He was previously the Executive Fitness Director for World’s Gyms, was a senior leader at FreeMotion Fitness and founded Fitness Beyond borders that he expanded to 8 countries internationally.

Mr. Strom commented, “I am really ecstatic about joining the passionate leadership team at XFit Brands. I can clearly see why there is a global demand for our portfolio of products. Beyond the company’s existing footprint, I am excited to leverage my deep international personal relationships in the Philippines, India, China, Singapore, Thailand, Dubai, Central and Latin America, the UK and Italy among others to expand the distribution on a broader scale to several new countries.”

Ted Joiner, President of XFit Brands commented, “We are extremely excited to have Jeremy join the leadership team. He has a great track record and is very respected in the industry, especially in the international fitness community. International has been a machine for us, but with the recent new large customers, we need more dedicated senior resources to lead the Division. Although International is only 40% of our total business today, under Jeremy’s leadership we expect to accelerate the expansion and growth.”

About XFit Brands®

XFit Brands, Inc. is one of the leading suppliers of functional fitness brands, products, and equipment sold at retail and fitness outlets worldwide. The company provides a full portfolio of products and services spanning Mixed Martial Arts and other High and low impact fitness regimes and owns the Throwdown® trademarks for its Functional Fitness and its MMA portfolio, and Transformations® in programming. The company’s portfolio of brands and products are sold in more than 20 countries around the world and supply many of the leading Gym and Fitness outlets throughout the United States. The Company’s websites are www.xfitbrands.com and www.throwdown.com.

Safe Harbor Disclosure

This press release contains forward-looking statements that are made pursuant to the safe harbor provisions within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are any statement reflecting management’s current expectations regarding future results of operations, economic performance, financial condition and achievements of XFit, including statements regarding XFit’s expectation to see continued growth. The forward-looking statements are based on the assumption that operating performance and results will continue in line with historical results. Management believes these assumptions to be reasonable but there is no assurance that they will prove to be accurate. Forward-looking statements, specifically those concerning future performance are subject to certain risks and uncertainties, and actual results may differ materially. XFit competes in a rapidly growing and transforming industry, and other factors disclosed in the Company’s filings with the Securities and Exchange Commission may affect the Company’s operations. Unless required by applicable law, XFit undertakes no obligation to update or revise any forward-looking statements.

For investor inquiries please contact:

Scott Cameron
investorrelations@xfitbrands.com
(949) 916-9680

Websites:

www.XFitBrands.com
www.Throwdown.com

SOURCE: XFit Brands, Inc.

ReleaseID: 441664